123 related articles for article (PubMed ID: 2439343)
21. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
Hussain M; Salwen W; Kucuk O; Ensley J
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
[TBL] [Abstract][Full Text] [Related]
22. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
Dimery IW; Legha SS
J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
[TBL] [Abstract][Full Text] [Related]
23. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
Abele R; Honegger HP; Grossenbacher R; Mermillod B; Kaplan E; Gervasi A; Wolfensberger M; Lehmann W; Cavalli F
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):47-53. PubMed ID: 2439344
[TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
Clavel M; Cognetti F; Dodion P; Wildiers J; Rosso R; Rossi A; Gignoux B; Van Rymenant M; Cortes-Funes H; Dalesio O
Cancer; 1987 Sep; 60(6):1173-7. PubMed ID: 2441836
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy with CDDP, 5-FU and PEP in head and neck malignant tumors.
Furusaka T; Kida A; Iizuka N; Kikuchi K; Tomita H
Auris Nasus Larynx; 1986; 13 Suppl 1():S135-42. PubMed ID: 2429646
[TBL] [Abstract][Full Text] [Related]
26. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
27. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
[TBL] [Abstract][Full Text] [Related]
28. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
[TBL] [Abstract][Full Text] [Related]
29. [Combination chemotherapy of cisplatin, vincristine and peplomycin for patients with head and neck carcinoma].
Tsukuda M; Tamamushi N; Mochimatsu I; Nakagawa C; Furukawa M; Kubota A; Hiiragi K; Nishimoto Y; Mitarai K; Oishi K
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):486-90. PubMed ID: 2420278
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
[No Abstract] [Full Text] [Related]
31. [The efficacy of polychemotherapy with cisplatin, methotrexate and 5-fluorouracil in inoperable forms of squamous cell cancer of the head and neck area].
Karaseva VV; Stepanov VG; Korolev VV
Vopr Onkol; 1992; 38(2):205-8. PubMed ID: 1300707
[TBL] [Abstract][Full Text] [Related]
32. [Indications for cytostatic therapy of recurrent cancer].
Schröder M; Stennert E; von Heyden HW; Scherpe A
HNO; 1984 Jun; 32(6):245-8. PubMed ID: 6206035
[TBL] [Abstract][Full Text] [Related]
33. Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neck.
Junor E; Canney P; Yosef H
Clin Oncol (R Coll Radiol); 1993; 5(1):43-5. PubMed ID: 8424914
[TBL] [Abstract][Full Text] [Related]
34. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
35. Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.
Rozencweig M; Dodion P; Bruntsch U; Gallmeier W; Clavel M; Gignoux B; Cortes Funes H; Cavalli F; Kirkpatrick A; Dalesio O
Cancer; 1984 Oct; 54(8):1499-503. PubMed ID: 6206936
[TBL] [Abstract][Full Text] [Related]
36. Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
Paccagnella A; Pappagallo GL; Segati R; Zorat P; Cavaniglia G; Lunghi F; Migliorini V; Frattina A; Bianco A; Sileni VC
Eur J Cancer; 1993; 29A(5):704-8. PubMed ID: 7682427
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin.
Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ
Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380
[No Abstract] [Full Text] [Related]
39. What is the optimal regimen of cisplatin plus 5-FU for head and neck cancer?
Chen MC
Oncology (Williston Park); 1990 Feb; 4(2):19. PubMed ID: 2143665
[No Abstract] [Full Text] [Related]
40. A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen.
Bitran JD; Goldman M
Am J Clin Oncol; 1985 Feb; 8(1):61-4. PubMed ID: 2581437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
